176 related articles for article (PubMed ID: 37843576)
1. Computed tomography radiomics identification of T1-2 and T3-4 stages of esophageal squamous cell carcinoma: two-dimensional or three-dimensional?
Li Y; Yang L; Gu X; Wang Q; Shi G; Zhang A; Yue M; Wang M; Ren J
Abdom Radiol (NY); 2024 Jan; 49(1):288-300. PubMed ID: 37843576
[TBL] [Abstract][Full Text] [Related]
2. Application of computed tomography-based radiomics in differential diagnosis of adenocarcinoma and squamous cell carcinoma at the esophagogastric junction.
Du KP; Huang WP; Liu SY; Chen YJ; Li LM; Liu XN; Han YJ; Zhou Y; Liu CC; Gao JB
World J Gastroenterol; 2022 Aug; 28(31):4363-4375. PubMed ID: 36159013
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography-based radiomics analysis to predict lymphovascular invasion in esophageal squamous cell carcinoma.
Peng H; Yang Q; Xue T; Chen Q; Li M; Duan S; Cai B; Feng F
Br J Radiol; 2022 Feb; 95(1130):20210918. PubMed ID: 34908477
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced CT radiomics features to preoperatively identify differences between tumor and proximal tumor-adjacent and tumor-distant tissues of resectable esophageal squamous cell carcinoma.
Gao D; Tan BG; Chen XQ; Zhou C; Ou J; Guo WW; Zhou HY; Li R; Zhang XM; Chen TW
Cancer Imaging; 2024 Jan; 24(1):11. PubMed ID: 38243339
[TBL] [Abstract][Full Text] [Related]
5. Preoperative CT radiomics of esophageal squamous cell carcinoma and lymph node to predict nodal disease with a high diagnostic capability.
Wu YP; Wu L; Ou J; Cao JM; Fu MY; Chen TW; Ouchi E; Hu J
Eur J Radiol; 2024 Jan; 170():111197. PubMed ID: 37992611
[TBL] [Abstract][Full Text] [Related]
6. Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
Zhu Y; Yao W; Xu BC; Lei YY; Guo QK; Liu LZ; Li HJ; Xu M; Yan J; Chang DD; Feng ST; Zhu ZH
BMC Cancer; 2021 Oct; 21(1):1167. PubMed ID: 34717582
[TBL] [Abstract][Full Text] [Related]
7. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models.
Xie C; Hu Y; Han L; Fu J; Vardhanabhuti V; Yang H
Ann Surg Oncol; 2022 Dec; 29(13):8117-8126. PubMed ID: 36018524
[TBL] [Abstract][Full Text] [Related]
9. Radiomics-clinical nomogram for preoperative lymph node metastasis prediction in esophageal carcinoma.
Geng X; Zhang Y; Li Y; Cai Y; Liu J; Geng T; Meng X; Hao F
Br J Radiol; 2024 Feb; 97(1155):652-659. PubMed ID: 38268475
[TBL] [Abstract][Full Text] [Related]
10. Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant Ovarian Tumors.
Li S; Liu J; Xiong Y; Han Y; Pang P; Luo P; Fan B
Biomed Res Int; 2022; 2022():5952296. PubMed ID: 35224097
[TBL] [Abstract][Full Text] [Related]
11. Potential value of CT-based comprehensive nomogram in predicting occult lymph node metastasis of esophageal squamous cell paralaryngeal nerves: a two-center study.
Xue T; Wan X; Zhou T; Zou Q; Ma C; Chen J
J Transl Med; 2024 Apr; 22(1):399. PubMed ID: 38689366
[TBL] [Abstract][Full Text] [Related]
12. Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089).
Peng G; Zhan Y; Wu Y; Zeng C; Wang S; Guo L; Liu W; Luo L; Wang R; Huang K; Huang B; Chen J; Chen C
Front Oncol; 2022; 12():988859. PubMed ID: 36387160
[TBL] [Abstract][Full Text] [Related]
13. Machine learning model based on enhanced CT radiomics for the preoperative prediction of lymphovascular invasion in esophageal squamous cell carcinoma.
Wang Y; Bai G; Huang M; Chen W
Front Oncol; 2024; 14():1308317. PubMed ID: 38549935
[TBL] [Abstract][Full Text] [Related]
14. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
[TBL] [Abstract][Full Text] [Related]
15. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
[TBL] [Abstract][Full Text] [Related]
16. Decoding tumor stage by peritumoral and intratumoral radiomics in resectable esophageal squamous cell carcinoma.
Tan XZ; Ma R; Liu P; Xiao CH; Zhang HH; Yang F; Liang CH; Liu ZY
Abdom Radiol (NY); 2024 Jan; 49(1):301-311. PubMed ID: 37831168
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Prediction of Perineural Invasion in Oesophageal Squamous Cell Carcinoma Based on CT Radiomics Nomogram: A Multicenter Study.
Zhou H; Zhou J; Qin C; Tian Q; Zhou S; Qin Y; Wu Y; Shi J; Feng F
Acad Radiol; 2024 Apr; 31(4):1355-1366. PubMed ID: 37949700
[TBL] [Abstract][Full Text] [Related]
18. CT radiomics in the identification of preoperative understaging in patients with clinical stage T1-2N0 esophageal squamous cell carcinoma.
Zhao B; Yan S; Jia ZY; Zhu HT; Shi YJ; Li XT; Qu JR; Sun YS
Quant Imaging Med Surg; 2023 Dec; 13(12):7996-8008. PubMed ID: 38106287
[TBL] [Abstract][Full Text] [Related]
19. A CT-Based Radiomics Nomogram Model for Differentiating Primary Malignant Melanoma of the Esophagus from Esophageal Squamous Cell Carcinoma.
Shi YJ; Zhu HT; Yan S; Li XT; Zhang XY; Sun YS
Biomed Res Int; 2023; 2023():6057196. PubMed ID: 36860814
[TBL] [Abstract][Full Text] [Related]
20. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]